155 related articles for article (PubMed ID: 38050555)
1. A Pharmacovigilance Study of Drug-Induced Glaucoma Utilizing the Japanese Adverse Event Reporting System.
Kozaru M; Iida T; Hosohata K
Clin Ophthalmol; 2023; 17():3645-3653. PubMed ID: 38050555
[TBL] [Abstract][Full Text] [Related]
2. Drug-induced tubulointerstitial nephritis in a retrospective study using spontaneous reporting system database.
Oyama S; Hosohata K; Inada A; Niinomi I; Mori Y; Yamaguchi Y; Uchida M; Iwanaga K
Ther Clin Risk Manag; 2018; 14():1599-1604. PubMed ID: 30233195
[TBL] [Abstract][Full Text] [Related]
3. Surveillance of drugs that most frequently induce acute kidney injury: A pharmacovigilance approach.
Hosohata K; Inada A; Oyama S; Furushima D; Yamada H; Iwanaga K
J Clin Pharm Ther; 2019 Feb; 44(1):49-53. PubMed ID: 30014591
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Adverse Event Profiles of Tumor Necrosis Factor-Alfa Inhibitors: Analysis of a Spontaneous Reporting Database.
Wakabayashi T; Hosohata K; Oyama S; Inada A; Ueno S; Kambara H; Iida T; Nakatsuji T; Uchida M; Iwanaga K
Ther Clin Risk Manag; 2020; 16():741-747. PubMed ID: 32884275
[TBL] [Abstract][Full Text] [Related]
5. Adverse event profiles of drugs used for treatment of juvenile idiopathic arthritis according to spontaneous reporting system database.
Niinomi I; Oyama S; Inada A; Wakabayashi T; Hirai T; Kambara H; Iida T; Uchida M; Sano Y; Hosohata K
Int J Clin Pharmacol Ther; 2022 Sep; 60(9):402-407. PubMed ID: 35924642
[TBL] [Abstract][Full Text] [Related]
6. Drug-induced thrombotic microangiopathy using the Japanese pharmacovigilance database.
Niinomi I; Hosohata K; Oyama S; Inada A; Hirai T; Iwanaga K
Int J Clin Pharmacol Ther; 2020 Oct; 58(10):543-549. PubMed ID: 32631486
[TBL] [Abstract][Full Text] [Related]
7. Adverse Cutaneous Drug Reactions Associated with Old- and New- Generation Antiepileptic Drugs Using the Japanese Pharmacovigilance Database.
Hosohata K; Inada A; Oyama S; Niinomi I; Wakabayashi T; Iwanaga K
Clin Drug Investig; 2019 Apr; 39(4):363-368. PubMed ID: 30689189
[TBL] [Abstract][Full Text] [Related]
8. Pharmacovigilance Assessment of Drug-Induced Acute Pancreatitis Using a Spontaneous Reporting Database.
Niinomi I; Hosohata K; Oyama S; Inada A; Wakabayashi T; Iwanaga K
Int J Toxicol; 2019; 38(6):487-492. PubMed ID: 31470743
[TBL] [Abstract][Full Text] [Related]
9. Current status of adverse event profile of tacrolimus in patients with solid organ transplantation from a pharmacovigilance study.
Kambara H; Oyama S; Inada A; Niinomi I; Wakabayashi T; Hosohata K
Int J Clin Pharmacol Ther; 2021 Dec; 59(12):753-759. PubMed ID: 34402788
[TBL] [Abstract][Full Text] [Related]
10. Drug-Associated Acute Kidney Injury Identified in the United States Food and Drug Administration Adverse Event Reporting System Database.
Welch HK; Kellum JA; Kane-Gill SL
Pharmacotherapy; 2018 Aug; 38(8):785-793. PubMed ID: 29883524
[TBL] [Abstract][Full Text] [Related]
11. Analysis of Corticosteroid-Induced Glaucoma Using the Japanese Adverse Drug Event Reporting Database.
Kawabe A; Uesawa Y
Pharmaceuticals (Basel); 2023 Jun; 16(7):. PubMed ID: 37513860
[TBL] [Abstract][Full Text] [Related]
12. Drug-induced hyperglycemia in the Japanese Adverse Drug Event Report database: association of evelolimus use with diabetes.
Konishi H; Shirakawa J; Arai M; Terauchi Y
Endocr J; 2019 Jun; 66(6):571-574. PubMed ID: 30944270
[TBL] [Abstract][Full Text] [Related]
13. Blind Spots in Therapy: Unveiling Drug-Induced Angle-Closure Glaucoma Through a National Analysis.
Aftab OM; Khan H; Khouri AS
Ophthalmol Glaucoma; 2024 Apr; ():. PubMed ID: 38679326
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular Toxicities Associated with Anaplastic Lymphoma Kinase Inhibitors: A Disproportionality Analysis of the WHO Pharmacovigilance Database (VigiBase).
Niimura T; Miyata K; Hamano H; Nounin Y; Unten H; Yoshino M; Mitsuboshi S; Aizawa F; Yagi K; Koyama T; Goda M; Kanda Y; Izawa-Ishizawa Y; Zamami Y; Ishizawa K
Drug Saf; 2023 Jun; 46(6):545-552. PubMed ID: 37106270
[TBL] [Abstract][Full Text] [Related]
15. Safety profile of vonoprazan compared with proton pump inhibitors: insight from a pharmacovigilance study.
Kambara H; Hosohata K; Nakatsuji T; Ueno S; Oyama S; Inada A; Niinomi I; Wakabayashi T; Iwanaga K
Pharmazie; 2020 Oct; 75(10):527-530. PubMed ID: 33305731
[TBL] [Abstract][Full Text] [Related]
16. Reports of sexual disorders related to serotonin reuptake inhibitors in the French pharmacovigilance database: an example of underreporting.
Trenque T; Maura G; Herlem E; Vallet C; Sole E; Auriche P; Drame M
Drug Saf; 2013 Jul; 36(7):515-9. PubMed ID: 23728950
[TBL] [Abstract][Full Text] [Related]
17. Data-Driven Identification of Adverse Event Reporting Patterns for Japan in VigiBase, the WHO Global Database of Individual Case Safety Reports.
Wakao R; Taavola H; Sandberg L; Iwasa E; Soejima S; Chandler R; Norén GN
Drug Saf; 2019 Dec; 42(12):1487-1498. PubMed ID: 31559542
[TBL] [Abstract][Full Text] [Related]
18. Fluid retention-associated adverse events in patients treated with BCR::ABL1 inhibitors based on FDA Adverse Event Reporting System (FAERS): a retrospective pharmacovigilance study.
Huang J; Cai J; Ye Q; Jiang Q; Lin H; Wu L
BMJ Open; 2023 Aug; 13(8):e071456. PubMed ID: 37536976
[TBL] [Abstract][Full Text] [Related]
19. Analysis of Adverse Drug Reaction Risk in Elderly Patients Using the Japanese Adverse Drug Event Report (JADER) Database.
Chisaki Y; Aoji S; Yano Y
Biol Pharm Bull; 2017; 40(6):824-829. PubMed ID: 28566626
[TBL] [Abstract][Full Text] [Related]
20. Liver injury in children: signal analysis of suspected drugs based on the food and drug administration adverse event reporting system.
Liu Y; Li H; Huang L; Wan C; Wang H; Jiao X; Zeng L; Jia Z; Cheng G; Zhang L; Zhang W; Zhang L
BMC Pediatr; 2023 Sep; 23(1):492. PubMed ID: 37770847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]